NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-158-1998-0-US-09 VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION US DIV 12/471,049 8168195 Abandoned PDF
CC E-063-2008-1-PCT-01 Use Of Functionalized Higher Generation (G) Dendrimer Nanoparticles (G5, G6 And G7) With A Neutralized Exterior For Imaging And Treatment Of Malignant Solid Tumors (cancers) Via Intravenous Administration PCT PCT COMB PCT/US2009/003164 Expired
NIA E-134-2009-0-US-01 Engineering Rhythmic And Responsive Biological Pacemakers Based on The Enhancement Of Cell Intracellular Signaling Targeting Both Ca Cycling And Sarcolemma US 61/180,491 Abandoned
NCI E-191-2009-0-US-01 Akt-Ser473 Phosphorylation And Taxane-Based Chemotherapy US 61/180,558 Abandoned
NCI E-207-2009-0-US-01 New Processes For Preparation Of Dendrimer-Based Bifunctional Diethylenetriaminepentaacetic Acid And DOTA Gd(III) MR Contrast Agent Derivatives US 61/180,327 Abandoned
NCI E-182-2008-0-PCT-02 Use Of Suppressive Oligonucleotides To Prevent/treat Silicosis And Asbestosis PCT PCT PCT/US2009/044739 Expired
NCI E-182-2008-0-EP-03 Method of Treating Pneumoconiosis With oligodeoxynucleotides EP National Stage 09751520.9 Abandoned
NCI E-274-2009-0-US-01 A Novel Tool To Evaluate Fetal Health. US 61/170,742 Abandoned
NCI E-316-2008-0-US-02 Methods And Systems Using Therapeutic, Diagnostic or Prophylactic Magnetic Agents US ORD 12/468,746 8579787 Abandoned PDF
NCI E-192-2009-0-US-01 Prevention Of Tumor Recurrence Through Inhibition Of Fibrosis, Integrin Signaling, Src And ERK Activation And Actin Stress Fiber Formation. US 61/179,641 Abandoned
NIDDK E-015-1996-0-US-20 HUMAN LUTEINIZING HORMONE SUPERAGONISTS US DIV 12/467,081 8044187 Abandoned PDF
NCI E-091-2008-0-PCT-02 Development Of A Highly Sensitive ELISA-based Polo-like Kinase 1 (Plk1) Activity Assay PCT PCT PCT/US2009/044202 Expired
NCI E-181-2009-0-US-01 Development Of Peptide Mimetic Ligands Of Polo-like Kinase L Polo Box Domain US 61/178,593 Abandoned
NCI E-163-2009-0-US-01 A Panel Of Fully Human Monoclonal Antibodies To The Same Epitope Of An Unknown Cell Surface Antigen Expressed In B-cell Lymphocytic Leukemia (B-CLL) US 61/178,688 Abandoned
NHLBI E-249-2006-2-US-03 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device US National Stage 12/514,990 8211171 Issued PDF
NCI E-258-2008-0-PCT-02 OXOBENZINDOLIZINOQUINOLINES AND USES THEREOF PCT PCT PCT/US2009/043905 Abandoned
NCI E-193-2009-0-US-01 A 50-gene Predictor Of Chemoresistance US 61/178,392 Abandoned
NCATS E-187-2009-0-US-01 Development Of Inhibitors Of The Alpha IIb Beta 3 Receptor. US 61/178,483 Abandoned
NCI E-257-2008-0-JP-31 Melanoma Associated Peptide Analogues And Vaccines Against Melanoma JP DIV 115844/2009 Expired
NIMH E-155-2008-1-PCT-01 Radiotracers For Imaging Cannabinoid Sub-Type 1 (CB-1) Receptor PCT PCT COMB PCT/US2009/043491 Expired
NCI E-192-2008-1-PCT-02 Optimization Of Expression Of Multimeric Proteins PCT PCT PCT/US2009/043481 Expired
NIEHS E-170-2000-0-US-05 A Non-Steroidal Anti-Inflammatory Drug Related Gene (NAG-1) And Secreted Protein That Has Anti-Tumorigenic Properties US DIV 12/463,666 Abandoned
NCI E-197-2009-0-US-01 TREM-like Transcript-1 Protects Against Inflammation-associated Hemorrhage By Facilitating Platelet Aggregation In Mice And Humans US 61/177,242 Abandoned
NCI E-285-2006-2-US-02 Differential Gene Expression In Physiological And Pathological Angiogenesis US National Stage 12/514,297 Abandoned
NIEHS E-156-2009-0-US-01 Composition And Methods for the Prevention and Treatment of Lupus Nephritis Using Anti-dsDNA Germline Antibodies US 61/176,615 Abandoned
NIDCR E-118-2009-0-US-01 Compound Deletions Of TGF-beta Receptor I And Pten Genes Cause Head And Neck Squamous Cell Carcinoma US 61/176,723 Abandoned
NIAID E-029-2007-0-US-03 Recombinant Virus with Diminished Latency and Methods of Using Same US National Stage 12/514,011 10166285 Issued PDF
NCI E-071-1992-2-JP-12 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA JP DIV 2009-112524 Expired
NIDCR E-185-2009-0-US-01 Use Of A Hybrid Adenoretroviral Vector To Prevent Radiation-induced Oral Mucositis Following Gene Transfer To Salivary Glands US 61/176,210 Abandoned
NCI E-159-2009-0-US-01 Mutation Of Critcal Lysines In The LAT Adapter Molecular Leads To Enhance T Cell Signalling US 61/176,231 Abandoned
NIAID E-189-2008-2-EP-04 LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN EP National Stage 09743563.0 Issued
NIAID E-189-2008-2-MX-07 LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN MX National Stage MX/a/2010/012069 Issued
NIAID E-189-2008-2-US-03 LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN US National Stage 12/436,398 8603808 Issued PDF
NIAID E-189-2008-2-TN-02 Leishmania Vaccine Using Sand Fly Salivary Immunogen TN National Stage 2010/0500 Issued
NCI E-256-2006-0-SG-10 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs SG National Stage 200903196-4 Abandoned
NCI E-256-2006-0-NZ-09 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs NZ National Stage 576769 Abandoned
NCI E-014-2007-0-NZ-14 SELF-ASSEMBLING NANOPARTICLES COMPOSED OF TRANSMEMBRANE PEPTIDES AND THEIR APPLICATION FOR SPECIFIC INTRA-TUMOR DELIVERY OF ANTI-CANCER DRUGS NZ National Stage 576467 Abandoned
NCI E-256-2006-0-ZA-12 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs ZA National Stage 2009/03125 Abandoned
NIAID E-189-2008-2-PCT-01 LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN PCT PCT COMB PCT/US2009/042980 Expired
NCI E-072-2008-0-PCT-02 HIV Immunogen and Method of Making and Using Same PCT PCT PCT/US2009/043054 Expired
NHLBI E-173-2009-0-US-01 Device And Method For Sterile Removal Of Sample From Cryopreserved Bag US 61/175,131 Abandoned
NCI E-050-2007-2-US-06 MicroRNA Expression Signature For Predicting Survival And Metastases in Hepatocellular Carcinoma US National Stage 12/513,219 8252538 Abandoned PDF
NCI E-160-2006-0-US-04 Azonafide Derived Tumor and Cancer Targeting Compounds US National Stage 12/441,029 8008316 Issued PDF
NCI E-256-2006-0-JP-08 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs JP National Stage 2009-535502 Abandoned
NCI E-059-1997-0-US-19 RECOMBINANT Antibodies And IMMUNO-CONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS US DIV 12/433,737 9592304 Abandoned PDF
NCI E-123-2008-0-PCT-02 Asparagine Substitution To Prevent Deamidation Of IL-15Asparagine Substitution To Prevent Deamidation Of IL-15Asparagine PCT PCT PCT/US2009/042355 Expired
NINDS E-160-2009-1-EP-01 Quinone derivative 2, 3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis EP ORD 09006030.2 Abandoned
NINDS E-160-2009-0-US-01 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis US 61/174,170 Abandoned
NCI E-183-2009-0-US-01 The Natural Product Schweinfurthin A And Synthetic Schweinfurthin Analogs Specifically Inhibit NF1-null Cells And May Be Useful As A Therapy For Neurofibromatosis Type 1. US 61/174,338 Abandoned
NCI E-170-2009-0-US-01 Methods Of Preparing Lymphocytes That Express Interleukin-12 And Their Use In The Treatment Of Cancer US 61/174,046 Abandoned